A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

NCT02443155 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: NNC0114-0006
DRUG: liraglutide
DRUG: placebo

Sponsor

Novo Nordisk A/S